Objectives: There is considerable evidence that personality disorders, including borderline personality disorder (BPD), tend to co-occur with chronic pain. There is also evidence that mood disorders co-occur with chronic pain conditions. Given the central role of affective instability and negative mood states in BPD, we proposed that affective features of depression, anxiety, and hostility may account for the association between BPD features and the severity of pain reported in a patient sample.
B orderline personality disorder (BPD) is characterized by marked instability of mood, impulsivity, self-harm behaviors, interpersonal problems, and identity disturbances (APA, 2000) . There is increasing interest in examining medical comorbidity associated with BPD, including health behaviors and treatment seeking and medical conditions such as pain symptoms. 1 There is some evidence showing that in general, personality disorders (PDs) tend to co-occur with pain disorders. [2] [3] [4] [5] [6] Studies of injured patient populations found the percentage of patients with PDs among injured patient populations to be as high as 51%, 3 81%, 7 and 77%. 8 Monti et al 6 found that 60% to 64% of patients with chronic pain conditions were diagnosed with an Axis II personality disorder. Fishbain et al 5 found that 59% of their pain sample met criteria for a PD. Other studies reporting rates of PDs among pain patients report lower percentages; for example, Large 9 found that PDs were present in 40% of their sample, Reich, Tupin, and Abramowitz 10 reported rates of 37%, and Gatchel et al 2 found that 24% of participants being treated for acute back pain met criteria for a PD. However, even these lower estimates are clearly higher than PD rates estimated for the general population, which are between 5.9% and 13.5%. 7 Addressing how PDs may contribute to the chronicity of pain problems, Gatchel, Polatin, and Kinney 2 found that a PD diagnosis upon entering treatment for an acute back pain episode was associated with the development of painrelated disability status 6 months later. Thus, maladaptive personality traits may be associated with less ability to cope with pain or injury, increase the risk of noncompliance, and so predisposes to delayed recovery. 7, 11 Although there is less research on the association between pain and BPD specifically, there is some evidence to support that BPD may be common among individuals with pain disorders. Descriptions in the literature 11 suggest that the personality features common among individuals with some pain disorders, such as Sudeck syndrome, include affective lability that is a core feature of BPD. 12 Furthermore, the high rate of comorbidity between chronic pain and PDs generally suggests that there is a high probability that BPD features may be common among pain patients.
Although Monti et al 6 did not find an excess of BPD among their pain patients, Polatin et al found that 15% of their sample met criteria for BPD. 3 In their sample of 17 participants being treated for pain, Sansone et al found that between 5 and 8 of these participants (47.1%) met criteria for BPD. 13 In contrast, Sansone, Pole, Dakroub, and Butler 14 did not find evidence of BPD features in their sample of 106 participants who were being treated for pain, although in this study only the Self-Harm Inventory was used as the measure of BPD features. Although only 1 study has examined medical problems among BPD patients, Frankenburg and Zanarini 15 report that individuals with more chronic forms of BPD are more likely to experience pain-related conditions such as fibromyalgia and temporomandibular joint syndrome. Thus, taken together, the studies cited above suggest that BPD may be comorbid with pain conditions. Additional research is needed on this topic for a number of reasons. First, only a few studies have examined this relationship specifically, and in these studies the focus is typically on the presence or absence of disorder rather than an examination of severity of BPD features. Although the presence or absence of disorder is relevant for diagnostic purposes, dimensional theories of BPD 16 suggest that BPD is a continuum of personality features. From this perspective, individuals who have significant BPD symptoms may be more prone to pain and somatic symptoms, even if they do not necessarily meet diagnostic criteria for BPD. Thus, research aimed at understanding how these features covary with other health conditions is important. One purpose of this study was to examine the association between BPD features and pain and somatic symptoms using a dimensional measure of BPD, among a large patient population.
A second purpose of this study was to test whether affective dysregulation may account for an association between BPD features and pain and somatic symptoms. BPD is characterized by frequent and intense mood swings, typically switching between negative emotional states of anxiety or fear, depression or dysphoria, and anger, hostility, or irritability. 12 Some have suggested 17 that affective dysregulation may be the underlying feature of BPD that contributes to the range of symptoms associated with this disorder. It has been argued that the negative affectivity and severe mood swings among individuals with BPD contribute to interpersonal problems, a lack of clear self-concept or identity, and the urge to overcome these emotions using impulsive or self-harm behaviors such as gambling, substance use, cutting, or suicide attempts. This has been supported by research showing that affective instability partially accounts for changes in other BPD features over time, such as interpersonal problems, identity disturbances, and self-harm behaviors. 18 We therefore propose that affective dysregulation may also account for the elevated levels of somatic and pain symptoms among individuals with BPD features.
There is considerable evidence supporting the association between pain and negative mood. [19] [20] [21] [22] [23] [24] For instance, Atkinson et al 20 found that compared with men without a history of back pain, men with chronic back pain had higher rates of anxiety disorders and major depression. In their nationally representative sample, McWilliams, Cox, and Enns 21 found that mood disorders were more prevalent among those with chronic pain. These included depressive disorders (depression, dysthymia), anxiety disorders (generalized anxiety disorder, panic disorder with or without agoraphobia), phobias (simple and social), and posttraumatic stress disorder, even after controlling for demographics such as age, gender, income, and ethnicity. Similarly, research has found that somatic symptoms also tend to be associated with depression. 22 Given that affective dysregulation in the form of negative mood is a predominant feature of BPD, affective disturbance may account for the association between BPD features and pain and somatic symptoms.
In sum, the purposes of this study were (1) to test the association between BPD features and pain symptoms in a large, patient population, and (2) to test whether affective disturbance accounts for the association between BPD features and pain and somatic symptoms. Specifically, we expected that there would be an association between BPD features and pain and somatic symptoms, but that affective disturbance such as depression and anxiety would account for this association.
METHODS

Participants and Procedure
Participants included 340 male and 437 female patients being treated for pain and injury, who were between the ages of 18 and 65 years (M=38.52, SD=10.95). Eighty-three percent of the participants were White, 7.6% Black, 5.4% Hispanic, 2.6% Native American, 0.9% Asian, and 0.5% ''Other.'' Participants also reported their highest level of educational attainment, with 13% receiving less than 4 years of high school, 27% reporting a high school education, 39% reporting some college or technical school, and 19% reporting graduating from college or beyond.
The data used in this study were part of a larger study using the Battery for Health Improvement. To create the patient sample, the Battery for Health Improvement 2 (BHI 2) was administered to 777 rehabilitation patients who were under treatment for pain or a physical injury and were from 30 states in all 4 geographic regions of the USA. They were recruited by posters or flyers provided to them by their providers and were from a variety of settings: acute physical therapy, work hardening programs, chronic pain programs, physician offices, and vocational rehabilitation settings. These patients were also drawn from various payer systems (Medicare/Medicaid, private insurance, worker's compensation, and auto insurance), and their diagnoses included a range of orthopedic injuries, headache and head injuries, fibromyalgia, and complex regional pain syndrome. Any patient who expressed an interest was allowed entrance into the study group. The only exclusion criteria were being less than 18 or over 65, and not able to read at the sixth-grade level. All participants were administered the BHI 2, plus 1 or more other tests. Test administration could take up to 3 hours, depending on what tests the participant had been asked to take. Participants were reimbursed $20 to 40 for their participation.
All 777 rehabilitation patients were administered the BHI 2 anonymously and signed an informed consent indicating that the information would be used for research purposes only and that no results or feedback would be given. Patients were informed that the information would not influence the course of their clinical care. Duration of pain (in days) was determined using the difference between the date the patient reported as the day the condition began subtracted from the date the survey was completed (based on the fact that all participants were currently being treated for pain or injury at the time the survey was given). The average duration of pain in this sample was approximately 2 years (M=764.84 d, SD=1544.209 d). The minimum duration of pain was 2 days and maximum duration was 16,174 days (or approximately 45 y).
Participants were being treated for a range of pain conditions. Twelve percent of the participants were being treated for headaches, 6.9% for whiplash, 8.1% for nonwhiplash cervical sprains, 6% for carpal tunnel syndrome, 25.2% for upper extremity injury or pain, 2.2% for thoracic outlet syndrome, 44.4% for lower back pain or injury, 25.4% for lower extremity injury or pain, 1.4% for reflex sympathetic dystrophy, 1.4% for fibromyalgia, and 17.6% for ''other'' conditions. For additional information about these participants, please see Bruns and Disorbio. 25 Measures A number of indicators are relevant to the experience of pain. These include the experience of pain in specific parts of the body, the recency of pain experiences, and other physical or somatic symptoms that tend to cooccur with pain. Owing to these complex issues in pain assessment, in this study, we used a number of measures to capture the severity of pain and related symptoms. The first was a pain symptoms measure that addressed the level of pain in each body part experienced in the past month. Second, a somatic symptoms scale was used to assess a variety of physical symptoms that may accompany pain, such as nausea, discomfort, difficulty concentrating, and increased heart rate. In addition to these composite measures assessing the presence of pain and somatic symptoms, we also measured pain severity by asking about the highest and lowest overall pain levels in the past month.
The Battery for Health Improvement 2 (BHI 2) is a self-report instrument intended for the biopsychosocial assessment of medical patients. The BHI 2 was used in this study as it (1) was developed for the assessment of patients with injury and pain 25 ; (2) is a standardized test with evidence of validity and reliability 25 ; (3) has both medical patient and community norm groups; (4) is short enough to be practical in the clinical setting (35 min); (5) has undergone 2, favorable independent peer reviews by the Buros Institute 26, 27 ; (6) has been integrated into clinical protocols [28] [29] [30] ; (7) is based on a biopsychosocial theory 31 ; (8) has been found to predict the outcome of multidisciplinary treatment for pain 32 ; (9) has been identified by various authors as being a test consider for chronic pain assessment [33] [34] [35] [36] [37] ; and (10) assesses pain, mood, and BPD features.
The BHI 2 test contains 18 scales: Two validity scales (Self-Disclosure and Defensiveness); 4 Physical Symptoms Scales (Somatic Complaints, Pain complaints, Functional complaints, Muscular Bracing); 3 Affective Scales (Depression, Anxiety, Hostility); 5 Character Scales (Borderline, Symptom Dependency, Chronic Maladjustment, Substance Abuse, Perseverance); and 4 Psychosocial Scales (Family Dysfunction, Survivor of Violence, Doctor Dissatisfaction, Job Dissatisfaction). The BHI 2 Job Dissatisfaction Scale was not included in the analysis in this study as many of the participants were not in the workforce. 25 The definitions and reliability estimates of the BHI 2 measures used in this study are listed in Table 1 . All of the measures in this study were self-report.
Borderline items were tested for content validity using interjudge agreement from a panel of 12 expert judges, to map on to the predominant features of Borderline Personality Disorder, including the DSM-IV BPD features of identity disturbances, self-destructive behavior, impulsivity, interpersonal problems, feelings of emptiness, and affective instability. Convergent validity evidence for the Borderline scale was established during scale development using the Millon Clinical Multiaxial Inventory-III. 25, 38 Convergent validity evidence for the depression, anxiety, and hostility scales was tested during scale development using the Minnesota Multiphasic Personality Inventory-2 39 , Millon Clinical Multiaxial Inventory-III 38 , others. 25 Testretest reliability was based on a test-retest interval of 1.5 weeks (see Table 1 ).
RESULTS
Descriptive Statistics
Descriptive statistics for the BHI 2 Borderline Scale, Affective Scales, Pain Complaints Scale and Somatic Complaints Scale, and individual pain items, are presented in Table 2 . Table 3 provides bivariate correlations among all variables.
A series of multiple regression analyses were used to test the hypothesis that BPD features were associated with pain complaints, somatic complaints, highest pain in the past month, and lowest pain in the past month, controlling for gender. As shown in Table 4 , BPD features scores were associated with all pain-related variables, controlling for gender and payer type.
On the basis of the theories of core features of BPD and literature showing an association between pain and affect, we predicted that affective disturbances would account for the association between BPD features and pain or somatic symptoms. Thus, a series of hierarchical regressions were conducted wherein affective scores (depression, anxiety, hostility) were entered along with gender in the first step, and BPD features scores were entered in the second step to determine whether BPD features scores conferred significant association above depression, anxiety, and hostility scores. The results of these analyses are presented in Tables 5 to 8 . As predicted, after controlling for affect scales, there was no longer a significant positive association between BPD features scores and pain and related symptoms.
DISCUSSION
In this study, we found that BPD features scores were associated with total pain complaints, total somatic complaints, highest levels of pain in the past month, and lowest levels of pain in the past month. Individuals with higher BPD features scores reported higher pain and somatic complaints scores, and higher reports for the highest and lowest amount of pain experienced in the past month. As predicted, these associations were no longer significant after controlling for affective scales measuring depression, anxiety, and hostility. This indicates that affective dysregulation accounts for the high rates of pain symptoms among individuals with BPD, consistent with theories emphasizing that a core feature of BPD is affective dysregulation, 17 and evidence that this feature may be a predominant factor in the presentation of other symptoms of the disorder. 18 The results of the regression analyses indicate that depression was particularly relevant to the association between Borderline features and pain symptoms. Depression scores consistently showed the largest effect in accounting for pain and related symptoms. This is consistent with literature showing that major depressive disorder is prevalent among chronic pain patients. 20, 22 The present results also show some evidence for an association between anxiety and pain and related symptoms, although this effect was not as strong. However, this is consistent with some literature showing that anxiety may also be related to pain symptoms. 20, 21, 23 The most noteworthy limitation of this study was the use of a correlational design. As we did not use a longitudinal design, it is not possible to determine whether BPD features are contributing to pain, or vice versa. However, these results do point to an association between these conditions and that the mechanism driving this association seems to involve affect. The exclusive use of self-report measures in this study is also a significant limitation. Whereas the efficiency of the self-report measure used enabled us to sample a large patient population, this nevertheless presents the weaknesses associated with self-report measures including issues of self-presentation (which, although the responses were anonymous, still may involve self-deception or lack of awareness of one's own symptoms). An implication of this is the lack of diagnostic information, such as the rates of relevant DSM-IV diagnoses (BPD, MDD, etc.) in this sample, or differences in these findings across diagnostic categories. These would be important questions to address in future research using formal diagnostic information. An additional limitation is the diversity of the sample in terms of the types of pain conditions, medical settings or treatment types, and pain duration, making it difficult to determine the generalizeability of the results. The potential for self-selection bias is also a weakness of this study. Patients were recruited through posters or flyers provided by caregivers, and received monetary compensation for participation. The extent to which this biased our sample is unknown.
There are a number of theoretical and practical implications of these results. First, they point to the importance of understanding the association between personality disorders, affect, and pain. Additional research is needed to determine the direction of these effects, and the mechanisms involved in the link between emotions, pain, and personality features. Understanding how these experiences may contribute to or prolong each other is important. For example, there is some evidence that pain may contribute to affective disorders such as depression, 40 suggesting the possibility that pain may also contribute to BPD affective personality disorder features. However, there is also evidence that behaviors associated with personality disorder features may inhibit recovery from pain or painrelated injuries, 7, 11 suggesting that these personality disorder features may precipitate unsuccessful recovery that results in chronic pain.
Second, these results have implications for treatment of individuals with BPD features and pain. Specifically, they suggest that using treatments targeting affective disturbances, especially depressive features, may also help with pain or somatic complaints. These could include either the use of pharmacotherapies to manage state symptoms, or long-term psychotherapeutic treatments in the attempt to attain remission of the disorder. For example, Dialectical Behavioral Therapy 17 is a treatment focused on the improvement of BPD affective disturbances, which has shown improvements over treatment as usual in randomized controlled trials. 41 However, research is needed to directly assess improvements in pain symptoms using dialectical behavioral therapy.
According to American Psychiatric Association guidelines, 42 the specific dimensions of BPD call for different pharmacologic approaches in the management of symptoms. On the basis of these findings, this has implications for the treatment of BPD somatic symptoms. Specifically, according to the American Psychiatric Association, 42 antidepressants are indicated for management of affective disturbances, whereas mood stabilizers are indicated for impulsive behaviors, and antipsychotics for perceptual disturbances. In their review, Bellino, Paradiso, and Bogetto 43 found that these recommendations are generally supported in randomized controlled trials on pharmacotherapies for BPD, especially as they relate to affective and impulsive features. They found that BPD affective disturbances, including depression, were most likely to improve with SSRIs or MAOIs, whereas mood stabilizers (eg, antiepileptics) showed improvements in impulsive features. 43 Thus, based on the present results, individuals with BPD who suffer from pain or somatic symptoms may show improvement in these symptoms with antidepressants, but not necessarily with pharmacotherapies used to manage some of the other BPD symptoms.
Although additional research is needed, there is some evidence that antidepressants may indeed be more efficacious for BPD depression and pain compared with other pharmacotherapies. Markovitz 44 found an improvement in somatic symptoms (headache and premenstrual symptoms) among patients with BPD at the end of a 14-week fluoxetine trial, whereas Rothrock et al 45 did not find evidence of improvement in migraine symptoms or depression among BPD patients treated using antiepileptic drug therapy along with a standard migraine treatment protocol. Although additional research is needed on the effects of various pharmacologic treatments on BPD somatic symptoms specifically, these studies provide initial support for the utility of antidepressants over other pharmacotherapies in treating these symptoms. In sum, this study highlights the role of affective disturbance, especially depression, in the connection between BPD features and pain and somatic symptoms. This has theoretical importance, and with additional research, may lead to improved treatment efficacy for patients presenting with these symptoms. 
